Clinical trial • Phase I | Phase I/II • Oncology
BG-C0979 for Advanced solid tumors
Phase I | Phase I/II trial of BG-C0979 for Advanced solid tumors. open-label. 61 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase I | Phase I/II
Key dates
- Initial CTIS Submission Date
- 20-02-2026
- First CTIS Authorization Date
- 30-04-2026
Trial design
open-label Phase I | Phase I/II trial across 4 sites in Spain.
- Open Label
- Yes
- Target Sample Size
- 61
Eligibility
Recruits 61 Vulnerable population not selected; no special consent/assent handling mentioned..
- Vulnerable Population
- Vulnerable population not selected; no special consent/assent handling mentioned.
Recruitment
- Planned Sample Size
- 61
- Recruitment Window Months
- 35
Geography
- Total Number Of Sites
- 4
- Total Number Of Participants
- 24
Spain
- Earliest CTIS Part Ii Submission Date
- 08-04-2026
- Latest Decision Or Authorization Date
- 30-04-2026
- Processing Time Days
- 22
- Number Of Sites
- 4
- Number Of Participants
- 24
Sites
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Medical Oncology
- Principal Investigator Name
- Víctor Moreno García
- Principal Investigator Email
- victor.moreno@startmadrid.com
- Contact Person Name
- Víctor Moreno García
- Contact Person Email
- victor.moreno@startmadrid.com
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Medical Oncology
- Principal Investigator Name
- Elena Garralda Cabanas
- Principal Investigator Email
- egarralda@vhio.net
- Contact Person Name
- Elena Garralda Cabanas
- Contact Person Email
- egarralda@vhio.net
- Site Name
- Hospital Universitario Quironsalud Madrid
- Department Name
- Medical Oncology
- Principal Investigator Name
- Valentina Boni
- Principal Investigator Email
- vboni@nextoncology.eu
- Contact Person Name
- Valentina Boni
- Contact Person Email
- vboni@nextoncology.eu
- Site Name
- Hospital Clinic De Barcelona
- Department Name
- Medical Oncology
- Principal Investigator Name
- Iván Manuel Victoria Ruiz
- Principal Investigator Email
- ivictori@recerca.clinic.cat
- Contact Person Name
- Iván Manuel Victoria Ruiz
- Contact Person Email
- ivictori@recerca.clinic.cat
Sponsor
Primary sponsor
- Full Name
- BeOne Medicines I GmbH
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Switzerland
Investigational products
- Investigational Product Name
- BG-C0979
- First In Human
- Yes
Related trials
Other published trials that may interest you.